Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mireia Sueca-Comes
Observed name:
Mireia Sueca Comes
Institution:
BioLineRx Ltd. (Israel)
Observed institutions:
Consejo Superior de Investigaciones Científicas,
University of Nottingham,
Universitat de València,
Institute for Integrative Systems Biology,
BioLineRx Ltd. (Israel),
Universitat Rovira i Virgili
show all 6
ORCID:
0000-0002-0966-3199
Observed ORCID:
0000-0002-0966-3199
OpenAlex ID:
A5035409104
CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer
2018
·
Teresa P. Raposo
, Mireia Sueca Comes
, et al.
·
Experimental and Molecular Pathology
·
12
PDF
The role of mesenchymal cells in cholangiocarcinoma
2024
·
Mireia Sueca-Comes
, Elena Cristina Rusu
, et al.
·
Disease Models & Mechanisms
·
5
PDF
Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome
2022
·
Mireia Sueca-Comes
, Elena Cristina Rusu
, et al.
·
Pharmacological Reviews
·
4
PDF
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
2023
·
Kyaw Zwar Myint
, Mireia Sueca-Comes
, et al.
·
Frontiers in Oncology
·
2
Deep Insights Without Clearing: An Optimized Protocol for Patient-Derived Whole-Organoid Immunofluorescence Imaging
2026
·
Laura Gull
, Mireia Sueca-Comes
, et al.
·
Methods in molecular biology
Show more works
View as search
Works count:
5
Citation count:
23
H-index:
3
I10-index:
1
Year
Topic
Type
